Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper ...

Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet syndrome in all territories outside Canada, Mexico and the US. Dravet syndrome ...

Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 ...

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

Biogen will receive rights to commercialize zorevunersen outside the US, Canada, and Mexico, paying $165 million upfront and other milestone payments.

A new study finds large amounts of “white hydrogen” may exist within mountain ranges, raising hopes this clean-burning gas ...

Thanks to the growing field of epigenetics, we're learning more about the interplay of genetic inheritance and environment in ...

With Next on Netflix 2025 out of the way, we have a pretty solid list of the majority of the biggest movies destined to be released over the next year. Given the marketing push for ...